Apellis Pharmaceuticals to Host Conference Call on October 30, 2025, to Discuss Third Quarter 2025 F, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced ...

Participants must register in advance for the live call. After registering, instructions on how to join the call will automatically be emailed, including dial-in information as well as a unique ...

PHILADELPHIA--(BUSINESS WIRE)--Aramark (NYSE:ARMK), a global leader in food and facilities management, announced that it will host a conference call to review its fourth quarter and full year fiscal ...

BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) announced a conference call and webcast to discuss regulatory updates for the nomlabofusp clinical development program for Friedreich’s ...

On Thursday, October 30, 2025, Mastercard Incorporated (NYSE: MA) will release its third quarter 2025 financial results. The company will host a conference call to discuss these results at 9:00 a.m.

BlackSky Technology Inc. (NYSE: BKSY) will host a live webcast and conference call to discuss third quarter 2025 financial results and its business outlook on Thursday, November 6, 2025, at 8:30 a.m.

CAESAREA, Israel, Oct. 27, 2025 /PRNewswire/ -- Max Stock Limited (TASE: MAXO) (the "Company") today announced it will host a conference call (LINK) on November 19, 2025 at 8:00 a.m. Eastern Time / ...

WEST MELBOURNE, FLORIDA / ACCESS Newswire / October 23, 2025 / BK Technologies Corporation (NYSE American:BKTI) (the "Company" or "BK Technologies") will host an investor conference call with a slide ...

Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in ...

TRAVERSE CITY, Mich., Oct. 21, 2025 /PRNewswire/ -- Hagerty, Inc. (NYSE: HGTY), an automotive enthusiast brand and a leading specialty vehicle insurance provider, today announced it will report its ...

NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that it will ...